| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 24.0 | 26.3 | 8.1 |
| Total income | 24.0 | 26.3 | 8.1 |
| Profit before exceptional items & tax | 0.9 | 0.1 | 0.0 |
| Profit before tax | 0.9 | 0.1 | 0.0 |
| Net profit | 0.7 | 0.1 | 0.0 |
| Operating margin | 3.8% | 0.4% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, quarter on quarter | +600.00% |
|---|---|
| Revenue, year on year | +196.30% |
BSE results filing, NSE: SHIVMED. Figures extracted from the filing.
Bandaram Pharma Packtech Ltd: key numbers
- Share price
- ₹20.49
- Market cap
- ₹36.82 Cr
- Revenue (annual)
- ₹62.92 Cr
- Net profit (annual)
- ₹1.01 Cr
- P/E (TTM)
- 36.2×Sector 57.8×
- Promoter holding
- 62.66%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bandaram Pharma Packtech Ltd
All →Bandaram Pharma Packtech Board Meeting Date
Bandaram Pharma Packtech has scheduled a board meeting on 30.09.2026 to consider a proposal for a scheme of arrangement or amalgamation.
Bandaram Pharma Packtech Annual General Meeting
Bandaram Pharma Packtech Limited held its Annual General Meeting on September 24, 2026, approving financial statements and re-appointing auditors and directors.
Bandaram Pharma Packtech Q4 FY26 Results: Net Profit ₹0.1 Cr, Down 50.0% YoY
Bandaram Pharma Packtech Ltd reported revenue from operations of ₹26.3 Cr (+209.4% YoY) and net profit of ₹0.1 Cr (-50.0% YoY) for Q4 FY26.
- Key figure
- Net profit ₹0.1 Cr · -50.0% YoY